Abbott binaxnow covid-19 antigen test cards.

Ended Awarded Last action

Contract number
36C24223N0290
Awardee
Awarding agency
Obligated
$432,775

Award facts

Contract value 113% obligated
$384,532.13 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Lockhart, FL 32810, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00005 · Decrease MOD for bronx -$234,177
Funding Only Action P00010 -$48,242
Funding Only Action P00009 · Abbott binaxnow covid-19 antigen test cards decrease MOD for bath -$22,714
Funding Only Action P00007 · Abbott binaxnow covid-19 antigen test cards decrease MOD for buffalo -$42,011
Funding Only Action P00008 · Abbott binaxnow covid-19 antigen test cards decrease MOD for albany -$40,202
Funding Only Action P00004 · Abbott binaxnow covid-19 antigen test cards decrease MOD for new jersey -$55,881
Funding Only Action P00003 · Abbott binaxnow covid-19 antigen test cards decrease MOD for hudson valley -$65,931
Funding Only Action P00006 · Abbott binaxnow covid-19 antigen test cards decrease MOD for buffalo -$15,679
Funding Only Action P00002 · Abbott binaxnow covid-19 antigen test cards decrease MOD for northport -$81,208
Additional Work (new agreement, FAR part 6 applies) P00001 · Abbott binaxnow covid-19 antigen test cards additional $55,278
Original award $935,300
Show all 11

About this award

Abbott Rapid DX North America LLC, doing business as Alere, was awarded a $384,532.13 firm fixed price call against the Blanket Purchase Agreement under the Master GSA Schedule contract "Invitro Diagnostics, Reagents, Test (FSS-65-VII)" to supply Abbott BINAXNOW COVID-19 Antigen Test Cards. Performance will occur in Lockhart, Florida through December 2023 for the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2. No set-aside designation was used for this contract to deliver Abbott's point-of-care immunoassay tests to diagnose coronavirus infections at VA facilities without instrumentation. Abbott Laboratories Inc. is the parent company of Abbott Rapid DX North America LLC.

Quick answers

Who was awarded contract 36C24223N0290?

36C24223N0290 was awarded to Abbott Rapid DX North America LLC by Veterans Integrated Service Network 2 (Veterans Health Administration) on January 5, 2023.

How much is contract 36C24223N0290 worth?

The government has obligated $432,775 on 36C24223N0290. Its current value, with exercised options, is $384,532.

Is contract 36C24223N0290 an order under another contract?

Yes. 36C24223N0290 is a BPA call under 36F79721D0073-36C24223A0006, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).

Was contract 36C24223N0290 competed?

The extent of competition for 36C24223N0290 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award